Table 2. Comparison of MetS profile among adult patients with T2D and MetS.
| Measurements | Control group (n = 18) | Intervention group (n = 18) | p value |
|---|---|---|---|
| WC, cm | −0.41 (−1.0007, 0.196) | 2.54 (1.8, 3.434)‡ | < 0.001 |
| TAG, mg/dL | −11.44 (−27.010, 4.121) | 37.89 (25.711, 50.078)‡ | < 0.001 |
| Cholesterol, mg/dL | −10.53 (−19.457, −1.603)* | 20.32 (12.019, 28.615)‡ | < 0.001 |
| HDL-C, mg/dL | 3.33 (0.428, 6.239)* | 2.28 (−1.912, 6.470) | 0.665 |
| LDL-C, mg/dL | −11.57 (−20.639, −2.509)* | 10.46 (1.139, 19.779)* | 0.001 |
| SBP, mmHg | −1.34 (3.604, 0.916) | 7.50 (3.662, 11.338)† | < 0.001 |
| DBP, mmHg | −2.78 (−5.505, 0.051)* | 2.78 (−0.761, 6.317) | 0.013 |
| FBS, mg/dL | 2.78 (−3.518, 13.851) | 43.55 (31.474, 55.637)‡ | < 0.001 |
Values are presented as mean difference (95% confidence interval). One-way repeated measures analysis of variance between and within the groups analyses were applied, followed by pairwise comparison with confidence interval adjustment. Mean difference have calculated follow as: value at baseline − value after 8 weeks of intervention.
MetS, metabolic syndrome; T2D, type 2 diabetes; WC, waist circumference; TAG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood sugar.
Asterisk significantly different by paired t-test between baseline and 8th week in the same intervention group, *p < 0.05; †p < 0.01; ‡p < 0.001.